» Articles » PMID: 36249096

Combination of Serum Test and Questionnaire in Early Gastric Cancer Screening

Overview
Date 2022 Oct 17
PMID 36249096
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We aimed to analyze the predictive role of serum test and questionnaire in Early Gastric Cancer in The First Affiliated Hospital of Xingtai Medical College, Hebei Province from 2019 to 2020.

Methods: In this prospective study, 280 medical examiners underwent questionnaire, serum test and gastroscopy. They were divided into Gastric cancer (GC) and Non-Gastric cancer (NGC) group. NGC group was divided into Low-grade intraepithelial neoplasia (LGIN), Chronic atrophic gastritis (CAG) and Non-chronic atrophic gastritis (NCAG) group.

Results: Age, drinking, sex and Gastrin-17(G-17) was respectively independent risk factors for GC. Age, drinking and G-17 was independent risk factors for GC in men. G-17 of GC group was higher than that of LGIN and NCAG group (<0.05). Pepsinogen I/II ratio (PGR) of GC was lower than that of NCAG group (<0.05). There was no significant difference between Pepsinogen I (PGI) and Pepsinogen II (PGII) in the four groups. -immunoglobulin G antibodies (-IgG) of LGIN group was significantly higher than that of CAG and NCAG group in gastritis group (P<0.008). G-17≥42.95 pmol/L, age≥69years, male and drinking can predict GC.

Conclusion: Older, drinking, men and high G-17 could respectively predict GC. Especially in men, older, drinking and high G-17 could affect the occurrence of GC. G-17, age, drinking and sex used respectively to screen high-risk populations for GC were more efficient than combined screening. GC had a higher serum G-17 and a lower PG than other gastric diseases.

Citing Articles

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer.

Wang Y, Liu H, Li X, Jin J, Yan B Front Oncol. 2025; 15:1521868.

PMID: 39959662 PMC: 11825325. DOI: 10.3389/fonc.2025.1521868.


Effects of Infection with Different Types of on Gastric Secretion Function: A Cross-Sectional Clinical Study.

Wang J, Qiao D, Wang Y, Xiong R, Ding X, Zhang W Int J Gen Med. 2024; 17:4539-4549.

PMID: 39398484 PMC: 11471097. DOI: 10.2147/IJGM.S477480.


Analysis of gastrin-17 and its related influencing factors in physical examination results.

Zeng J, Shen Y, Xu S, Yang R Immun Inflamm Dis. 2023; 11(10):e993.

PMID: 37904688 PMC: 10604568. DOI: 10.1002/iid3.993.

References
1.
Shen H, Xiong K, Wu X, Cheng S, Lou Q, Jin H . The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China. Gastroenterol Res Pract. 2021; 2021:6894248. PMC: 8055402. DOI: 10.1155/2021/6894248. View

2.
Yu G, Wang G, Wang H, Mo F, Tang B . The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. Neoplasma. 2019; 66(4):637-640. DOI: 10.4149/neo_2018_180825N647. View

3.
Gong E, Ahn J, Jung H, Lim H, Choi K, Lee J . Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol. 2013; 29(2):301-9. DOI: 10.1111/jgh.12387. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View